Blog

8 June, 2020

Collaboration between the healthcare system and the pharmaceutical industry, key for Spain to consolidate its leadership in clinical trials

Representatives of the Spanish Medicines Agency, patient associations, hospitals and the pharmaceutical industry debate in a webinar on how to promote clinical research in Spain Measures […]
26 May, 2020

The clinical trial, a value bet for the healthcare system, professionals, patients and industry.

On May 20, Clinical Trial Day is celebrated worldwide About 80% of the studies that are launched in Spain are driven by the pharmaceutical industry Spain […]
25 May, 2020

Novo Nordisk Spain increases patients in clinical trials by 50% in three years

Source: www.immedicohospitalario.es Since 2018, Novo Nordisk Spain has increased the number of patients in clinical trials by 50%, as detailed by Fernando Fuentes, head of Clinical […]
22 May, 2020

Almost a thousand clinical trials, more than 230 drugs and vaccines to combat Covid-19

Industrial property is “the main reason why there is such a solid base of innovation from which to work to find solutions,” says the director of […]
14 May, 2020

World Asthma Day: fifty hundred medicines in development for one of the most prevalent pathologies

This chronic disease has an incidence of between 3 and 7% of the population in Spain, according to experts Treatments provide clear results in patients’ health […]
12 May, 2020

Drug research as an opportunity for Spain

In just a few months, Spain has launched 64 clinical trials with potential anti-coronavirus drugs, ranking first in Europe and fourth in the world. The brutal […]
27 April, 2020

Objective: to maintain clinical trials without putting patients’ health at risk

Farmaindustria participates in a Eupati webinar aimed at patients from all over Spain Explain how laboratories are working, in collaboration with researchers and hospitals, so that […]
21 April, 2020

New clinical trial designs and more resources for Spain to achieve excellence

Via: www.elglobal.es Clinical and industry experts carry out a decalogue with measures to strengthen the Spanish research system In recent years, Spain has positioned itself among […]
20 April, 2020

Spain, a world leader in conducting clinical trials of new drugs

Via: www.immedicohospitalario.es Farmaindustria has collected in a document the measures that 120 experts from hospital centers and pharmaceutical companies propose to boost Spanish leadership and attract […]
18 March, 2020

Exceptional measures for tests for problems derived from the emergency by COVID-19

Source: www.actasanitaria.com The Spanish Agency of Medicines and Health Products (AEMPS), as the competent national authority in the authorization of clinical trials, has proposed a series […]
9 March, 2020

The pharmaceutical industry warns of the risk of Europe becoming a non-driving, receiving market for innovation

The European employer of the innovative industry has its sights set on the roadmap of the Industrial Strategy for the sector, which will be published next […]
4 March, 2020

The pharmaceutical sector, the basis of a new production model in Spain

Source: www.expansion.com The pharmaceutical industry is positioned as a leading actor for the necessary evolution of the Spanish economy towards a productive model supported by innovation […]
24 February, 2020

Create the test that predicts the risk of infection in kidney transplants

Source: www.immedicohospitalario.es The clinical efficacy of this new diagnosed tool has been tested in five hospitals with clinical trials, which is a step towards personalized medicine […]
10 February, 2020

Drug R&D: increasingly high development costs and lower returns

The expected return on investment in new medicines stands at 1.8%, the lowest point in the last 10 years, according to a Deloitte report On the […]
7 February, 2020

SEFH joins the World Cancer Day recalling the importance of healthy habits and research

Source: www.immedicohospitalario.es The arrival of advanced therapies, such as CAR-T cells, immunotherapy or other targeted treatments and their incorporation into the assistance protocols are being able […]
6 February, 2020

Clinical research in Spain seeks new impulses to maintain its leadership position in Europe

Farmaindustria advocates strengthening the role of the Spanish Agency for Medicines and Health Products (Aemps) to maintain the competitiveness of our country in biomedical R&D The […]
5 February, 2020

The pharmaceutical industry responds to the increased incidence of cancer: one in two clinical trials focuses on oncology

The impulse to biomedical research in this area allows disease control for longer, increases survival and improves the quality of life of patients The Spanish Agency […]
28 January, 2020

Clinical trials, cost savings for the system and innovative therapies for the patient

They are essential to demonstrate the safety of medicines, but they also represent a significant cost savings in the health centers where they are carried out. […]
16 January, 2020

The Economic and Social Council advises the Government to promote investment in R&D

Source: www.actasanitaria.es Farmaindustria has reported that the Economic and Social Council (CES), a consultative body of the Government in socio-economic and labor matters, published a comprehensive […]
13 January, 2020

2019, a new year of “progress” and “remarkable progress” for pharmaceutical innovation

The European agency EMA gives green light to 30 new drugs and the US FDA, to 48 Hematology and oncology account for more than a third […]
10 January, 2020

The keys that can turn Spain into a reference for biomedical research

Source: www.20minutos.es Our country is one of the best conditions to host biomedical and pharmaceutical research projects, both national and international. In 1886, scientists Oskar Minkowski […]
8 January, 2020

The pharmaceutical industry accelerates against lung cancer, the one with the highest mortality in Spain

One in five clinical trials in Oncology in our country investigates this type of tumor, which causes 22,000 deaths per year The available treatments have tripled […]
11 December, 2019

“We have put the name of Vall d’Hebron on the map of world oncology”

  Source: www.immedicohospitalario.es Such a high percentage of participation in clinical research studies has no one. The Vall d’Hebron Institute of Oncology (VHIO) is a research […]
27 November, 2019

Andalusian high school students are interested in drug R&D

The Maternal and Child Hospital of Malaga hosted on Wednesday a new edition of the day ‘Bringing science closer to schools. Drug research and development ’, […]
20 November, 2019

Farmaindustria reinforces the collaboration to promote clinical research in Spain

Meeting with hospital pharmacists to exchange knowledge and experience between industry and professionals to promote trials It was agreed to establish a mixed working group to […]
15 November, 2019

#WeWontRest until we beat Alzheimer’s disease – together

Source: www.epfia.eu Unlocking the mystery behind Alzheimer’s disease and dementia and improving care for people require new types of partnership. As we navigate uncertain waters, we […]
11 November, 2019

The pharmaceutical industry reaffirms its commitment to R&D in rare diseases

The number of new treatments available against rare pathologies has multiplied by 20 in Europe since 2000 The industry insists on collaboration with governments and health […]
7 November, 2019

The pharmaceutical industry already invests more than 660 million euros a year in clinical research in Spain

It is one of the keys that explain why Spain has become one of the countries in Europe with better conditions to develop clinical trials of […]
5 November, 2019

Investment in R&D of the pharmaceutical industry, a value for the whole society

Experts from the Weber Foundation and Farmaindustria clear some doubts about drug spending and analyze research challenges. Source: www.farmaindustria.es The pharmaceutical sector is high risk; For […]
18 October, 2019

The pharmaceutical industry has in the R&D phase 140 new medicines against mental disorders

To the suffering of patients and relatives there are costs that in the European Union equal 4% of the GDP of the member countries This Thursday […]